Subject(s)
Brain Death , Tissue and Organ Procurement , Death , Humans , Organ Transplantation , Tissue DonorsABSTRACT
BACKGROUND: Cardiac abnormalities attributed to adrenergic surge are common after aneurysmal subarachnoid hemorrhage. Prescribed medications that block adrenergic stimulation may suppress the onset of cardiopulmonary compromise in patients after aneurysmal subarachnoid hemorrhage. OBJECTIVES: To compare the incidence of early cardiac complications between patients who reported prescribed use of ß-blockers and/or angiotensin-converting enzyme inhibitors before aneurysmal subarachnoid hemorrhage and patients who did not. METHODS: A retrospective review of 254 adult patients after acute aneurysmal subarachnoid hemorrhage who were enrolled in an existing R01 study. Demographic data and history were obtained from patients'/proxies' reports and charts. Cardiac enzyme levels, 12-lead electrocardiograms, and chest radiographs were obtained on admission. Holter monitoring and echocardiograms were completed as a part of the R01 study. RESULTS: Patients reporting prescribed use of angiotensin-converting enzyme inhibitors or ß-blockers before aneurysmal subarachnoid hemorrhage had more ventricular and supraventricular ectopy on a Holter report than did patients who did not (P < .05). When age, race, sex, and injury (Fisher grade) were controlled for, patients reporting use of ß-blockers were 8 times more likely than others to have occasional to frequent ventricular ectopy (P = .02). CONCLUSION: No concrete evidence was found that exposure to adrenergic blockade before aneurysmal subarachnoid hemorrhage provides protection from neurocardiac injury.
Subject(s)
Aneurysm, Ruptured/complications , Cardiovascular Agents/therapeutic use , Heart Diseases/etiology , Heart/physiopathology , Intracranial Aneurysm/complications , Subarachnoid Hemorrhage/complications , Adrenergic beta-Antagonists/adverse effects , Adrenergic beta-Antagonists/pharmacology , Adrenergic beta-Antagonists/therapeutic use , Adult , Age Distribution , Aged , Angiotensin-Converting Enzyme Inhibitors/adverse effects , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Cardiovascular Agents/adverse effects , Cardiovascular Agents/pharmacology , Female , Heart/drug effects , Heart Diseases/diagnosis , Heart Diseases/drug therapy , Heart Diseases/physiopathology , Humans , Male , Middle Aged , Retrospective Studies , Sex Distribution , Subarachnoid Hemorrhage/etiology , Survival Analysis , Young AdultSubject(s)
Decision Making , Negotiating , Standard of Care , Terminal Care/legislation & jurisprudence , HumansABSTRACT
THE CASE: The patient is a 27-year-old previously healthy male with a diagnosis of viral encephalitis with a lymphocytic pleocytosis on cerebrospinal fluid examination. For 3 months, he has been in status epilepticus (SE) on high doses of barbiturates, benzodiazepines, and ketamine and a ketogenic feeding-tube formula. He remains in burst suppression on continuous electroencephalography (EEG). He is trached and has a percutaneous endoscopic gastrostomy (PEG) feeding tube. He has been treated several times for pneumonia, and he is on a warming blanket and is on vasopressors to maintain his blood pressure. His vitals are stable and his lab work is within limits. The sedation is decreased under EEG guidance every 72 hours, after which he goes back into SE and heavy sedation is resumed. The latest magnetic resonance imaging (MRI) shows edema but otherwise no obvious permanent cortical damage. The family wants a realistic assessment of the likely outcome. The neurologist tells them the literature suggests the outlook is poor but not 100% fatal. As long as all of his other organs are functioning on life support, there is always a chance the seizures will stop at some time in the future, and so the neurologist recommends an open-ended intensive care unit (ICU) plan and hopes for that outcome.
Subject(s)
Hospital Costs , Intensive Care Units/economics , Resource Allocation/ethics , Adult , Encephalitis, Viral/complications , Encephalitis, Viral/physiopathology , Humans , Long-Term Care/economics , Male , Prognosis , Status Epilepticus/drug therapy , Status Epilepticus/etiologyABSTRACT
The nature of mankind is a concern for those in need. Disasters, both natural and manmade, have been with us since the beginning of recorded history but media coverage of them is a relatively new phenomenon. When these factors come together, there is great potential to both identify and serve the sick and injured. However, the mass media by its nature tends to enhance the humanistic aspect of rescue while minimizing the practical problems involved. We describe a recent scenario in Haiti that puts some of these complications into a practical perspective.
Subject(s)
Disaster Medicine/organization & administration , Mass MediaSubject(s)
Altruism , Disaster Medicine/organization & administration , Disasters , Humans , Internationality , Relief Work , VolunteersSubject(s)
Brain Death/diagnosis , Death , Tissue and Organ Procurement , Brain Death/classification , HumansABSTRACT
Critical care medicine has expanded the envelope of debilitating disease through the application of an aggressive and invasive care plan, part of which is designed to identify and reverse organ dysfunction before it proceeds to organ failure. For a select patient population, this care plan has been remarkably successful. But because patient selection is very broad, critical care sometimes yields amalgams of life in death: the state of being unable to participate in human life, unable to die, at least in the traditional sense. This work examines the emerging paradox of somatic versus brain death and why it matters to medical science.
Subject(s)
Bioethical Issues , Death , Brain Death/diagnosis , Critical Care , HumansABSTRACT
The definition of death has evolved to include the concept of brain death. The brainstem is an indispensable central integrative unit for all vital functions. The clinical criteria for brain death consist of the demonstration of the absence of function of the brainstem. Confirmatory testing, which mostly evaluates higher clinical function, is usually not required for the diagnosis of brain death.
Subject(s)
Brain Death , Brain Death/diagnosis , Brain Death/physiopathology , Brain Stem/anatomy & histology , Electroencephalography , Evoked Potentials, Auditory, Brain Stem/physiology , Humans , Life Support Care , PrognosisABSTRACT
Highly complex and specialized care plans sometimes overwhelm the comprehension of patients and families. Many optimistic surrogates of critically ill patients err on the side of desiring that everything be done but with a nebulous idea of what 'everything' entails. Physicians must work closely to educate surrogates as to the benefits versus the risks of treatment. Our roundtable experts ponder the question of whether providers possess the authority to interpret unilaterally the nature of requests for everything.